Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Glucocorticoid treatment of inflammatory disorders is associated with significant adverse effects related to glucocorticoid excess as well as adrenal insufficiency. This necessitates awareness of its use. We therefore investigated trends in systemic glucocorticoid use as well as morbidity and comedications among users. DESIGN: Cross-sectional drug utilisation study. METHODS: We conducted a population-based study of 926,314 users of systemic glucocorticoids (oral and injectable formulations) from 1999 to 2014 using Danish nationwide registries. We computed annual prevalence and incidence of systemic glucocorticoid use and prevalence of comedications and morbidity. Further, we assessed the annual amount of disease-modifying drug use. RESULTS: Of the 926,314 users of systemic glucocorticoids, 54% were female and median age at first-time use was 55 years. The annual prevalence was ≈ 3%, while the incidence was ≈ 1.4/100 person years (p-y). Both figures remained constant from 1999 to 2014. In the elderly, the annual prevalence was 6.7-7.7% (60-79 years of age) and 9.7-11% (≥80 years of age). Incidence increased among persons aged ≥80 years from 3.0/100 p-y in 1999 to 3.6/100 p-y in 2014. Concomitantly, the annual amount of for example methotrexate, azathioprine and tumour necrosis factor (TNF)-alpha agents increased and new biological agents emerged. The most frequent comedications were antibiotics (49%), cardiovascular drugs (38%) and NSAIDs (37%). CONCLUSIONS: Our findings confirm a widespread use of systemic glucocorticoids, especially in the elderly, which prevails despite increased use of disease-modifying drugs. The continuously prevalent use of glucocorticoid use constitutes a challenge for the endocrine community.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucocorticoids are among the most widely prescribed anti-inflammatory drugs worldwide (up to 3% of the population) (10-13), dispensed on medical prescription or as over-the-counter medications, the latter mostly as topic or transdermal formulations.”
From The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System (2022) · cites this paper as [12]
In the citing paper
“As many as 1–3% of the population are currently on GC treatment.”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [4]
Citations
Cites
Association between high serum total cortisol concentrations and mortality from COVID-19
Tan, T., Khoo, B., Mills, E. G., Phylactou, M., Patel, B., Eng, P. C., Thurston, L., Muzi, B., Meeran, K., Prevost, A. T., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30216-3 · Cited by 255
Laugesen, K., Petersen, I., Pedersen, L. H., Larsen, F. B., Jørgensen, J. O. L., & Sørensen, H. T. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030780 · Cited by 7
Self-citation
Cited by
Reincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Association between high serum total cortisol concentrations and mortality from COVID-19
Tan, T., Khoo, B., Mills, E. G., Phylactou, M., Patel, B., Eng, P. C., Thurston, L., Muzi, B., Meeran, K., Prevost, A. T., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30216-3 · Cited by 255
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. W. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 209
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Metadata
- Authors
- Laugesen, K., Jørgensen, J. O. L., Petersen, I., & Sørensen, H. T.
- Affiliations
- Aarhus University Hospital (DK)
- Corresponding author
- Laugesen, Kristina
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-09
- Volume
- 181
- Issue
- 3
- Pages
- 267-273
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2954179686
- Cited by
- 92
- References
- 2
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 18 · 2023: 20 · 2022: 15 · 2021: 7 · 2020: 6 · 2019: 1
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- systemic glucocorticoids, glucocorticoid excess, adrenal insufficiency, concomitant medications, disease-modifying drugs, methotrexate, azathioprine, TNF-alpha inhibitors, biologic agents, nonsteroidal anti-inflammatory drugs, antibiotics, cardiovascular drugs, elderly patients, inflammatory diseases, Denmark
- MeSH terms
- Adolescent, Adrenal Insufficiency, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Cross-Sectional Studies, Denmark, Female, Glucocorticoids, Humans, Infant, Infant, Newborn, Longitudinal Studies, Male, Middle Aged, Registries, Risk Factors, Young Adult, Inappropriate Prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark. https://app.cochat.ai/papers/10.1530/eje-19-0305
- The paper
- Laugesen, K., Jørgensen, J. O. L., Petersen, I., & Sørensen, H. T. (2019). Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark. European Journal of Endocrinology. https://doi.org/10.1530/eje-19-0305
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.